Dianilpidi-Tuaque 1.5%

Adult dosage

Only for intraperitoneal administration and not for intravenous use. Single-use product. For adults, 2.0L to 2.5L is injected into the peritoneal cavity based on a body surface area of 1.73m2. For continuous ambulatory peritoneal dialysis, it is usually performed 4 times a day. In automated peritoneal dialysis, it is generally performed using a machine at night for 4-5 cycles and a maximum of 2 times during the day.

This drug is used for treatment in peritoneal dialysis, and discontinuing treatment early can pose a threat to life, so it must be followed strictly according to the physician's instructions. A serious complication called encapsulating peritoneal sclerosis, which can occur rarely during peritoneal dialysis, has been reported, so if symptoms appear, notify the healthcare staff immediately. This medicine contains dextrose, which can cause severe allergic reactions in patients with corn allergies, so caution is required. Patients with severe lactic acidosis should not use this medication, and those at high risk for lactic acidosis should be carefully monitored before and during treatment. If being treated for other conditions, particularly patients with heart disease taking cardiac glycosides, they should periodically check electrolyte levels to prevent side effects. Diabetic patients must closely monitor blood sugar control during and after dialysis, adjusting the dosage of insulin or other medications as needed. Numerous diseases or conditions may render peritoneal dialysis unsuitable, therefore the physician must thoroughly assess the patient's condition before deciding on the use of this medication. Various adverse reactions such as peritonitis, electrolyte imbalances, and infections can occur during treatment, and if any abnormal symptoms arise, immediate consultation with healthcare staff is advised. Peritoneal dialysis solution must be used in a sterile condition, and if any damage, discoloration, or turbidity of the container is observed, it must not be used. In the case of overdose, dehydration, electrolyte disturbances, and hyperglycemia may occur, so the patient's weight and blood tests should be continuously monitored and adjusted according to the physician's instructions. Pregnant or nursing women should only use this medication if necessary, under the careful judgment of a physician. This medication requires dose adjustments and careful monitoring when administered to children or elderly patients, with particular consideration for the risk of hernia occurrence in the elderly prior to peritoneal dialysis. Finally, this drug should be stored away from direct sunlight and at room temperature, and any remaining dialysis solution should be discarded after use.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reactions, severe rashes with high fever, blisters, skin peel-off, pain in oral/eye mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by coughing and fever, respiratory problems, yellowing of skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and

Mild side effects

Abdominal pain, bleeding, peritonitis (abdominal pain, cloudy drainage fluid, sometimes fever), inflammation around the abdominal catheter, catheter damage or drainage difficulty, nausea, abdominal pain, diarrhea, constipation, hemorrhoids, vomiting, loss of appetite, abdominal distension, intestinal obstruction, hypokalemia, hyponatremia, hypercalcemia, hypophosphatemia, hyperlactatemia, hypomagnesemia, hypercholesterolemia, hypertriglyceridemia, metabolic acidosis, hypoproteinemia, hyperglycemia,

This medication must be stored in a sealed container at a temperature between 1 degree and 30 degrees Celsius at room temperature. Storing it this way helps maintain medication effectiveness and prevents deterioration.

Appearance

It is a colorless, transparent liquid formulation sealed in a transparent polyvinyl chloride bag with a light yellow hue. 5L/bag (automated peritoneal dialysis) is injected into the peritoneal dialysis solution bag in the order of infusion line, inner cap, connector, and rubber ring.

Package unit

2000, 2500ml/2 bags, 5000ml/bag